Veterinary Medicines

Detonervin 10 mg/ml, solution for injection for horses and cattle

Authorised
  • DETOMIDINE HYDROCHLORIDE FOR VETERINARY USE
Download as PDF

Product identification

Medicine name:
Detonervin 10 mg/ml, solution for injection for horses and cattle
Detonervin 10 mg/ml, oplossing voor injectie voor paarden en runderen detomidine hydrochloride
Active substance:
  • DETOMIDINE HYDROCHLORIDE FOR VETERINARY USE
Target species:
  • Cattle
  • Horse
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • DETOMIDINE HYDROCHLORIDE FOR VETERINARY USE
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        12
        hour
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        2
        day
  • Intravenous use
    • Cattle
      • Milk
        12
        hour
      • Meat and offal
        2
        day
    • Horse
      • Meat and offal
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Clear colourless glass (type I) vials closed with a coated bromobutyl rubber stopper (type I) and an aluminium cap with a polypropylene lid. 5 x 1 glass vials with 20 ml.
  • Clear colourless glass (type I) vials closed with a coated bromobutyl rubber stopper (type I) and an aluminium cap with a polypropylene lid. 5 x 1 glass vial with 5 ml.
  • Clear colourless glass (type I) vials closed with a coated bromobutyl rubber stopper (type I) and an aluminium cap with a polypropylene lid. 1 x 1 glass vial with 5 ml.
  • Clear colourless glass (type I) vials closed with a coated bromobutyl rubber stopper (type I) and an aluminium cap with a polypropylene lid. 1 x 1 glass vial with 20 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 106913
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0147/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/01/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 16/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."